C161H146Cl3F9N36O21 — CID 158622416
4-[[2-[4-chloro-3-[(E)-4-(dimethylamino)but-2-enoyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[3-chloro-4-[2-(dimethylcarbamoyl)-1-hydroxyprop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[4-chloro-3-[1-hydroxy-2-(morpholine-4-carbonyl)prop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;N-methyl-4-[[2-[4-(4-methyl-2-oxopent-3-enyl)-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[2-oxo-3-(pyrazol-1-ylmethyl)but-3-enyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[(prop-2-enoylamino)methyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide (PubChem CID 158622416) has the molecular formula C161H146Cl3F9N36O21 and a molecular weight of 3198.51 g/mol. Its IUPAC name is 4-[[2-[4-chloro-3-[(E)-4-(dimethylamino)but-2-enoyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[3-chloro-4-[2-(dimethylcarbamoyl)-1-hydroxyprop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[4-chloro-3-[1-hydroxy-2-(morpholine-4-carbonyl)prop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;N-methyl-4-[[2-[4-(4-methyl-2-oxopent-3-enyl)-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[2-oxo-3-(pyrazol-1-ylmethyl)but-3-enyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[(prop-2-enoylamino)methyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide.
| Compound Name | 4-[[2-[4-chloro-3-[(E)-4-(dimethylamino)but-2-enoyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[3-chloro-4-[2-(dimethylcarbamoyl)-1-hydroxyprop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[4-chloro-3-[1-hydroxy-2-(morpholine-4-carbonyl)prop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;N-methyl-4-[[2-[4-(4-methyl-2-oxopent-3-enyl)-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[2-oxo-3-(pyrazol-1-ylmethyl)but-3-enyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[(prop-2-enoylamino)methyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 158622416 |
| Molecular Formula | C161H146Cl3F9N36O21 |
| Molecular Weight | 3198.51 g/mol |
| Exact Mass | 3195.04 |
| IUPAC Name | 4-[[2-[4-chloro-3-[(E)-4-(dimethylamino)but-2-enoyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[3-chloro-4-[2-(dimethylcarbamoyl)-1-hydroxyprop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;4-[[2-[4-chloro-3-[1-hydroxy-2-(morpholine-4-carbonyl)prop-2-enyl]anilino]-3H-benzimidazol-5-yl]oxy]-N-methylpyridine-2-carboxamide;N-methyl-4-[[2-[4-(4-methyl-2-oxopent-3-enyl)-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[2-oxo-3-(pyrazol-1-ylmethyl)but-3-enyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide;N-methyl-4-[[2-[4-[(prop-2-enoylamino)methyl]-3-(trifluoromethyl)anilino]-3H-benzimidazol-5-yl]oxy]pyridine-2-carboxamide |
| SMILES | C=C(C(=O)N(C)C)C(O)c1ccc(Nc2nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3[nH]2)cc1Cl.C=C(C(=O)N1CCOCC1)C(O)c1cc(Nc2nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3[nH]2)ccc1Cl.C=C(Cn1cccn1)C(=O)Cc1ccc(Nc2nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3[nH]2)cc1C(F)(F)F.C=CC(=O)NCc1ccc(Nc2nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3[nH]2)cc1C(F)(F)F.CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(CC(=O)C=C(C)C)c(C(F)(F)F)c4)[nH]c3c2)ccn1.CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(=O)/C=C/CN(C)C)c4)[nH]c3c2)ccn1 |
| InChI | InChI=1S/C29H24F3N7O3.C28H27ClN6O5.C27H24F3N5O3.C26H25ClN6O4.C26H25ClN6O3.C25H21F3N6O3/c1-17(16-39-11-3-9-35-39)26(40)12-18-4-5-19(13-22(18)29(30,31)32)36-28-37-23-7-6-20(14-24(23)38-28)42-21-8-10-34-25(15-21)27(41)33-2;1-16(27(38)35-9-11-39-12-10-35)25(36)20-13-17(3-5-21(20)29)32-28-33-22-6-4-18(14-23(22)34-28)40-19-7-8-31-24(15-19)26(37)30-2;1-15(2)10-18(36)11-16-4-5-17(12-21(16)27(28,29)30)33-26-34-22-7-6-19(13-23(22)35-26)38-20-8-9-32-24(14-20)25(37)31-3;1-14(25(36)33(3)4)23(34)18-7-5-15(11-19(18)27)30-26-31-20-8-6-16(12-21(20)32-26)37-17-9-10-29-22(13-17)24(35)28-2;1-28-25(35)23-15-18(10-11-29-23)36-17-7-9-21-22(14-17)32-26(31-21)30-16-6-8-20(27)19(13-16)24(34)5-4-12-33(2)3;1-3-22(35)31-13-14-4-5-15(10-18(14)25(26,27)28)32-24-33-19-7-6-16(11-20(19)34-24)37-17-8-9-30-21(12-17)23(36)29-2/h3-11,13-15H,1,12,16H2,2H3,(H,33,41)(H2,36,37,38);3-8,13-15,25,36H,1,9-12H2,2H3,(H,30,37)(H2,32,33,34);4-10,12-14H,11H2,1-3H3,(H,31,37)(H2,33,34,35);5-13,23,34H,1H2,2-4H3,(H,28,35)(H2,30,31,32);4-11,13-15H,12H2,1-3H3,(H,28,35)(H2,30,31,32);3-12H,1,13H2,2H3,(H,29,36)(H,31,35)(H2,32,33,34)/b;;;;5-4+; |
| InChIKey | HYEAJHZULPZWCQ-LAZLYBKISA-N |
| XLogP | 29.01 |
| TPSA | 743.26 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 51 |
| Heavy Atoms | 230 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3198.51 |
| LogP ≤ 5 | 29.01 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 42 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|